Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Bevacizumab | Case report

Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2

Author: Anmar Abdul-Rahman

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Internal limiting membrane (ILM) drape sign is an important OCT characteristic of Macular telangiectasia type 2 (MacTel 2). Described here is a case where masking of the ILM drape sign occurred with bilateral foveal detachments in a patient with MacTel 2.

Case presentation

A 64-year old female was diagnosed with MacTel 2, four years prior to the current presentation on the basis of an OCT demonstrating bilateral ILM drape sign. Fluorescein angiography showed bilateral dilated, ectatic capillaries and late phase dye leak. At the current presentation there was bilateral gradual visual impairment over two months due to bilateral foveal detachments. Treatment with intravitreal Bevacizumab resulted in unmasking of the pre-existing ILM drape sign at 12 weeks. Visual acuity was reduced to counting fingers in the left eye with the neovascular membrane as a consequence of sub-retinal fibrosis, while the right eye maintained a vision of 6/12. A difference in the stage of the disease at presentation determined the long-term visual outcome after seven years of observation.

Conclusion

Foveal detachment can influence the OCT detectability of pre-existing foveal cystoid lesions. Visual prognosis at the final follow up was consistent with the interocular disparity of the disease stage at presentation.
Literature
1.
go back to reference Wu L. When is macular edema not macular edema? An update on macular telangiectasia type 2. Taiwan J Ophthalmol. 2015;5:149–55.CrossRef Wu L. When is macular edema not macular edema? An update on macular telangiectasia type 2. Taiwan J Ophthalmol. 2015;5:149–55.CrossRef
2.
go back to reference Wu L, Evans T, Arevalo JF. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, mac Tel 2). Surv Ophthalmol. 2013;58:536–59.CrossRef Wu L, Evans T, Arevalo JF. Idiopathic macular telangiectasia type 2 (idiopathic juxtafoveolar retinal telangiectasis type 2A, mac Tel 2). Surv Ophthalmol. 2013;58:536–59.CrossRef
3.
go back to reference Clemons TE, Gillies MC, Chew EY, et al. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel project report no. 2. Ophthalmic Epidemiol. 2010;17:66–73.CrossRef Clemons TE, Gillies MC, Chew EY, et al. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel) MacTel project report no. 2. Ophthalmic Epidemiol. 2010;17:66–73.CrossRef
4.
go back to reference Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:48–57.CrossRef Paunescu LA, Ko TH, Duker JS, et al. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:48–57.CrossRef
5.
go back to reference Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100:1536–46.CrossRef Gass JDM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis: update of classification and follow-up study. Ophthalmology. 1993;100:1536–46.CrossRef
Metadata
Title
Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2
Author
Anmar Abdul-Rahman
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Bevacizumab
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01485-y

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue